Used primarily in cancer research, it serves as a metabolite of gefitinib, a drug targeting non-small cell lung cancer. Researchers study it to understand drug metabolism and resistance mechanisms. It helps in developing strategies to enhance therapeutic efficacy and reduce adverse effects. Additionally, it aids in pharmacokinetic studies to optimize dosing regimens for better patient outcomes.